Dietary strategies for remission of type 2 diabetes: A narrative review.
Adrian BrownPaul D McArdleJulie TaplinDavid UnwinJennifer UnwinTrudi DeakinSean WheatleyCampbell MurdochAseem MalhotraDuane D MellorPublished in: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association (2021)
Type 2 diabetes (T2DM) is a growing health issue globally, which, until recently, was considered to be both chronic and progressive. Although having lifestyle and dietary changes as core components, treatments have focused on optimising glycaemic control using pharmaceutical agents. With data from bariatric surgery and, more recently, total diet replacement (TDR) studies that have set out to achieve remission, remission of T2DM has emerged as a treatment goal. A group of specialist dietitians and medical practitioners was convened, supported by the British Dietetic Association and Diabetes UK, to discuss dietary approaches to T2DM and consequently undertook a review of the available clinical trial and practice audit data regarding dietary approaches to remission of T2DM. Current available evidence suggests that a range of dietary approaches, including low energy diets (mostly using TDR) and low carbohydrate diets, can be used to support the achievement of euglycaemia and potentially remission. The most significant predictor of remission is weight loss and, although euglycaemia may occur on a low carbohydrate diet without weight loss, which does not meet some definitions of remission, it may rather constitute a 'state of mitigation' of T2DM. This technical point may not be considered as important for people living with T2DM, aside from that it may only last as long as the carbohydrate restriction is maintained. The possibility of actively treating T2DM along with the possibility of achieving remission should be discussed by healthcare professionals with people living with T2DM, along with a range of different dietary approaches that can help to achieve this.
Keyphrases
- weight loss
- glycemic control
- bariatric surgery
- type diabetes
- disease activity
- ulcerative colitis
- roux en y gastric bypass
- gastric bypass
- healthcare
- clinical trial
- cardiovascular disease
- primary care
- obese patients
- physical activity
- rheumatoid arthritis
- public health
- mental health
- systemic lupus erythematosus
- electronic health record
- multiple sclerosis
- randomized controlled trial
- climate change
- body mass index
- open label
- machine learning
- smoking cessation
- replacement therapy
- palliative care
- insulin resistance
- deep learning
- big data
- risk assessment